FDA intensifies US safety analysis probing into AstraZeneca coronavirus vaccine
US Regulators had ceased Phase 3 clinical trials of AstraZeneca coronavirus vaccine from September 6. The in-depth analysis of FDA...
US Regulators had ceased Phase 3 clinical trials of AstraZeneca coronavirus vaccine from September 6. The in-depth analysis of FDA...
Researchers from Florida have proved the effectiveness of AI in identifying coronavirus in lungs A computer algorithm was trained to...
The US-India "collaborative approach on therapeutics" was underlined as an excellent example of a positive global impact by the U.S. State Department. US-India...
THD NewsDesk, New Delhi: A joint statement by BCG and FICCI titled “Leapfrogging to a Digital Healthcare System: Reimaging Healthcare for...
THD NewsDesk, Mumbai : Centaur Pharmaceuticals is starting a diabetic foot ulcer remedy drug Woxheal. It is a New Chemical Entity...
THD NewsDesk, NEW DELHI: On September 30, Indian drug firm Panacea Biotec informed that it had received a warning letter from...
THD NewsDesk, VIRGINIA, USA: I2Pure, a US-based biotech company launched I2Cure, an antimicrobial bio-shield lotion in India on September 29....
THDNewsDesk, Bengaluru: Walmart-owned Flipkart has now entered the e-pharmacy area, following in the footsteps of Reliance and Amazon India. It...
THD NewsDesk, New Delhi: The Pharma giant, Sun Pharmaceuticals have declared their plan of expansion in China and Japan. As...
THD NewsDesk, Hyderabad: Indian Medical Association (IMA) has emphasised on the necessity for an attentive medical administrative service focusing on...
A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.
© 2025 - The Healthcare Daily